A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

NCT01636284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carinoma

Interventions

BIOLOGICAL: JX-594 recombinant vaccina GM-CSF

Sponsor

Jennerex Biotherapeutics